- Jerome Etienne, professor of microbiology,
- Oana Dumitrescu, resident in microbiology
- 1Université Lyon 1, Centre National de Référence des Staphylocoques, U851, Faculté Lyon Est, Lyon 69008, France
- jetienne{at}univ-lyon1.fr
Panton-Valentine leucocidin (PVL) is a cytotoxin produced by Staphylococcus aureus that lyses leucocytes by creating pores on the cell surface. PVL was first detected in meticillin susceptible S aureus (MSSA) and then later in meticillin resistant S aureus (MRSA). Awareness of diseases related to PVL has increased since the worldwide emergence of these community acquired MRSA strains. In the United States, PVL positive MRSA has been associated with outbreaks of skin and soft tissue infection and sporadic life threatening diseases.1 2 In contrast, in Europe, especially in the United Kingdom, PVL positive S aureus strains are more commonly meticillin susceptible.3 4 Therefore, in the US, Switzerland, and Canada national guidelines for managing PVL positive S aureus disease are recommended for MRSA infections and in the UK for both MRSA and MSSA infections.
Regardless of meticillin resistance, PVL positive S aureus cause either recurrent spontaneous skin infections or rare severe illnesses, such …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012